ADMA Biologics, Inc. ADMA
NASDAQ · United States · Health Technology
$10.01-0.02 (-0.25%)
Market open· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market open· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-08-05 | 0.16 | 0.16 | +1.0% | $124.40M | -0.8% | +12.9%$8.91→$10.06 |
| Q1 2026 | 2026-05-06 | 0.17 | 0.20 | -15.0% | — | — | -17.4%$10.25→$8.47 |
| Q4 2025 | 2026-02-25 | 0.22 | 0.20 | +10.0% | — | — | -2.2%$15.52→$15.18 |
| Q3 2025 | 2025-11-05 | 0.16 | 0.16 | 0.0% | — | — | -4.1%$14.63→$14.03 |
| Q2 2025 | 2025-08-06 | 0.14 | 0.14 | 0.0% | — | — | — |
| Q1 2025 | 2025-05-07 | 0.11 | 0.17 | -35.3% | — | — | — |
| Q4 2024 | 2025-03-03 | 0.14 | 0.15 | -6.7% | — | — | — |
| Q3 2024 | 2024-11-07 | 0.15 | 0.13 | +15.4% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.